EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cystic Fibrosis: A Journey through Time and Hope

Pascal Trouvé, Aude Saint Pierre, Claude Férec iD

International Journal of Molecular Sciences · 04.09.2024 · 25 (17) · 9599

DOI: 10.3390/ijms25179599 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.09.2024. Verfasst von Pascal Trouvé und 2 weiteren Autor:innen. Beteiligte Einrichtung: Univ Brest, Inserm, EFS, UMR 1078, 22 Avenue Camille Desmoulins, F-29200 Brest, France. Hauptthemen laut MEDLINE: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Just over thirty years is the span of a generation. It is also the time that has passed since the discovery of the gene responsible for cystic fibrosis. Today, it is safe to say that this discovery has revolutionized our understanding, research perspectives, and management of this disease, which was, thirty years ago, a pediatric condition with a grim prognosis. The aim of this review is to present the advances that science and medicine have brought to our understanding of the pathophysiology of the disease and its management, which in many ways, epitomizes modern molecular genetic research. Since the discovery of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in 1989, modeling the CFTR protein, deciphering its function as an ion channel, and identifying its molecular partners have led to numerous therapeutic advances. The most significant advancement in this field has been the discovery of protein modulators that can target its membrane localization and chloride channel activity. However, further progress is needed to ensure that all patients can benefit from a therapy tailored to their mutations, with the primary challenge being the development of treatments for mutations leading to a complete absence of the protein. The present review delves into the history of the multifaceted world of CF, covering main historical facts, current landscape, clinical management, emerging therapies, patient perspectives, and the importance of ongoing research, bridging science and medicine in the fight against the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorHumansMutationAnimals

Stichwörter der Autor:innen

cystic fibrosis

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorCFTR protein, human

Autor:innen und Institutionen

  • Univ Brest, Inserm, EFS, UMR 1078, 22 Avenue Camille Desmoulins, F-29200 Brest, France.

ORCID-Profile: Claude Férec

Zitieren

APA

Trouvé, P., Saint Pierre, A., & Férec, C. (2024). Cystic Fibrosis: A Journey through Time and Hope. International Journal of Molecular Sciences, 25(17), 9599. https://doi.org/10.3390/ijms25179599

Vancouver

Trouvé P, Saint Pierre A, Férec C. Cystic Fibrosis: A Journey through Time and Hope. International Journal of Molecular Sciences. 2024;25(17):9599. doi:10.3390/ijms25179599

BibTeX
@article{Trouv2024,
  author = {Trouvé, Pascal and Saint Pierre, Aude and Férec, Claude},
  title = {Cystic Fibrosis: A Journey through Time and Hope},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {17},
  pages = {9599},
  doi = {10.3390/ijms25179599}
}
Kostenlos starten →